Cytokinetics Announces First Commercial European Launch Of MYQORZO In Germany For Treatment Of Symptomatic Obstructive Hypertrophic Cardiomyopathy In Adult Patients

뉴스 본문을 불러오고 있어요.

Cytokinetics Announces First Commercial European Launch Of MYQORZO In Germany For Treatment Of Symptomatic Obstructive Hypertrophic Cardiomyopathy In Adult Patients | 웨이프 WAPE

Cytokinetics Announces First Commercial European Launch Of MYQORZO In Germany For Treatment Of Symptomatic Obstructive Hypertrophic Cardiomyopathy In Adult Patients

기사 요약

관련 종목

댓글 —